Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific,…
Luke Gill, Head of Oncology, and Will Chen, Global Head of Regulatory…
Authors: Luke Gill, Emerald Clinical Vice President, Global Head of Oncology Scientific…
Emerald Clinical Trials has acquired Hongyi Clinical Development Services, the independent China-based…
Author: Dan Gallagher, Emerald Clinical Trials SVP, Business Development. Dan Gallagher is…
Author: Tony Proctor, Emerald Clinical Trials Chief Financial Officer China’s biotech surge…
China’s Oncology Paradigm Shift: From Proof-of-Concept to FDA Registration Pathway — EXECUTIVE…
The 63rd ERA Congress, held June 3–6, 2026 in Glasgow, reinforced a…
Posts Authors:Jonathan Barratt, PhD, FRCP. The Mayer Professor of Renal Medicine, University…